Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(S)-2,6-diamino-N-((5S,8S,11S,14S,17S,20S,23S,26S)-8,11,20,23-tetrakis((1H-indol-3-yl)methyl)-1,30-diamino-14,17-bis(4-aminobutyl)-5-carbamoyl-7,10,13,16,19,22,25-heptaoxo-6,9,12,15,18,21,24-heptaazatriacontan-26-yl)hexanamide
ID: ALA5281642
Max Phase: Preclinical
Molecular Formula: C74H103N19O9
Molecular Weight: 1402.76
Associated Items: